Alpine Immune Science, Inc. (ALPN/USD) Experiences Breakout with Aggressive Buying
Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 minutes to learn more
Alpine Immune Science Inc. (ALPN) has exhibited a steady upward trend since late 2023. The stock broke above $8.60 and established itself at the $20 level by year-end. January 2024 saw renewed bullish momentum, exceeding the strength observed in late 2023. This consistent buying pressure propelled the price to double, reaching $40 by late March. ALPN maintained this level until today’s surge, which saw an aggressive move towards the $50 mark.
Alpine Immune Science, Inc. Market Data
- ALPN/USD Price Now: $47.23
- ALPN/USD Market Cap: $4.22 billion
- ALPN/USD Circulating Supply: 75 million
- ALPN/USD Total Supply: 50 billion
- ALPN/USD CoinMarketCap Ranking: #283
Key Levels
- Resistance: $50, $55, and $60.
- Support: $40, $35, and $30.
Alpine Immune Science, Inc. Market Analysis: The Indicators’ Point of View
The recent surge in buying pressure has fueled a significant price increase for Alpine Immune Science (ALPN). Considering the stock’s strong bullish run since late 2023, this uptrend may be attracting Fear of Missing Out (FOMO) buying from some traders. However, Bollinger Bands and the Relative Strength Index (RSI) currently suggest the market is nearing overbought territory, potentially indicating a price correction. Such a correction could be sizeable given the recent rapid price increase. Additionally, considering the crypto signal of the market’s performance since late last year, profit-taking by investors wary of an impending correction could further dampen the momentum.
ALPN/USD 4-Hour Chart Outlook
Alpine Immune Science (ALPN) experienced a sharp price surge, leading to a significant divergence on the Bollinger Bands indicator. The Relative Strength Index (RSI) also spiked above 70, reaching a peak of 85. This suggests the market may be entering overbought territory, potentially indicating a period of profit-taking. While current profit-taking appears muted compared to the recent bullish activity, it’s important to note that the RSI remains elevated. Therefore, a price correction remains a possibility before reaching the $50 level.